Literature DB >> 16163673

Help signals provided by lymphokines modulate the activation and apoptotic programs induced by partially agonistic peptides in specific cytotoxic T lymphocytes.

Michael Uhlin1, Elena Sandalova, Maria Gracia Masucci, Victor Levitsky.   

Abstract

Inefficient recognition of altered peptide ligands (APL) by specific CTL is believed to contribute to the failure of immune control over tumors and progressive viral infections. A link between deficient help signals and the appearance of CTL epitope mutants has been suggested by recent studies. However, the regulation of APL activity by immunologic help is not well understood. We analyzed the capacity of exogenous IL-2 and IL-15, which are physiologically produced by cells of the adaptive and innate immune system, respectively, to modulate proliferation, responsiveness to repeated stimulation and apoptotic programs triggered in specific CTL by either fully or partially agonistic peptide ligands. We show that signals induced by the lymphokines synergize with weak TCR signaling induced by partially agonistic APL, converting many of these peptides from inhibitory to stimulatory ligands. Some APL partially suppress the responsiveness of specific CTL to secondary stimulation, while this inhibitory effect is diminished if APL-stimulated cells are cultured in the presence of either of the lymphokines. We also demonstrate that IL-2 and IL-15 suppress up-regulation of the Bcl-2 family member Bim and induction of a death receptor-independent apoptotic program triggered by partially agonistic APL. Our results suggest that under conditions of insufficient immunologic help, partially agonistic APL may actively suppress specific CTL responses and become especially advantageous for immune escape of tumors or viruses.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16163673     DOI: 10.1002/eji.200526330

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  4 in total

1.  Changes in functional but not structural avidity during differentiation of CD8+ effector cells in vivo after virus infection.

Authors:  Samuel Amoah; Rama D Yammani; Jason M Grayson; Martha A Alexander-Miller
Journal:  J Immunol       Date:  2012-06-15       Impact factor: 5.422

2.  Alpha/beta T-cell depleted grafts as an immunological booster to treat graft failure after hematopoietic stem cell transplantation with HLA-matched related and unrelated donors.

Authors:  E Rådestad; H Wikell; M Engström; E Watz; B Sundberg; S Thunberg; M Uzunel; J Mattsson; M Uhlin
Journal:  J Immunol Res       Date:  2014-10-13       Impact factor: 4.818

3.  CXCR6 positions cytotoxic T cells to receive critical survival signals in the tumor microenvironment.

Authors:  Mauro Di Pilato; Raphael Kfuri-Rubens; Jasper N Pruessmann; Aleksandra J Ozga; Marius Messemaker; Bruno L Cadilha; Ramya Sivakumar; Chiara Cianciaruso; Ross D Warner; Francesco Marangoni; Esteban Carrizosa; Stefanie Lesch; James Billingsley; Daniel Perez-Ramos; Fidel Zavala; Esther Rheinbay; Andrew D Luster; Michael Y Gerner; Sebastian Kobold; Mikael J Pittet; Thorsten R Mempel
Journal:  Cell       Date:  2021-08-02       Impact factor: 66.850

4.  Donor Cell Composition and Reactivity Predict Risk of Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Darius Sairafi; Arwen Stikvoort; Jens Gertow; Jonas Mattsson; Michael Uhlin
Journal:  J Immunol Res       Date:  2016-11-14       Impact factor: 4.818

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.